Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continued Access to Emtricitabine for FTC-203 Completers
NCT00743340Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Nov 2005
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of emtricitabine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Gilead Sciences. Started Nov 2005; status: completed.
02
Drugs
emtricitabine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00743340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00743340.